Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;27(4):398-404.
doi: 10.1111/j.1464-5491.2010.02956.x.

Temporal patterns in overweight and obesity in Type 1 diabetes

B Conway  1 , R G Miller, T Costacou, L Fried, S Kelsey, R W Evans, T J Orchard
Affiliations

Temporal patterns in overweight and obesity in Type 1 diabetes

B Conway et al. Diabet Med. 2010 Apr.

Abstract

Aims: Time trends in overweight and obesity in the general population have been well documented; however, temporal patterns in Type 1 diabetes (T1DM) have not been thoroughly investigated. We therefore assessed temporal patterns in overweight and obesity and predictors of weight change in 589 individuals from the Pittsburgh Epidemiology of Diabetes Complications Study, a cohort of childhood-onset T1DM.

Methods: Participants were first seen in 1986-1988, when mean age and diabetes duration were 29 and 20 years, respectively, and biennially thereafter for 18 years. Overweight was defined as 25.0<or=body mass index (BMI)<30.0 kg/m2. Obesity was defined as BMI>or=30.0 kg/m2.

Results: At baseline, the prevalence of overweight and obesity were 28.6% and 3.4%, respectively. After 18 years' follow-up, the prevalence of overweight increased by 47% while the prevalence of obesity increased sevenfold. Seven per cent were on intensive insulin therapy (>or=3 insulin injections per day or on insulin pump) at baseline; by 2004-2007, this was 82%. Predictors of weight change were a higher baseline HbA1c, symptomatic autonomic neuropathy (inversely), overt nephropathy (inversely), and going onto intensive insulin therapy during follow-up.

Conclusions: These data demonstrate dramatic weight gain in T1DM and underscore the complexity of weight change in this disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests

We, the authors, have no competing interests to declare.

Figures

Figure 1
Figure 1
Temporal patterns in overweight and obesity in type 1 diabetes.
Figure 2
Figure 2
Temporal patterns in intensive insulin therapy in adults with type 1 diabetes.
See this image and copyright information in PMC

References

    1. Ogden C, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555. - PubMed
    1. Flegal K, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727. - PubMed
    1. Mokdad A, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522. - PubMed
    1. Williams K, et al. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care. 1999;22:1084–1091. - PubMed
    1. Purnell J, et al. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA. 1998;280:140–146. - PMC - PubMed

Publication types

MeSH terms